Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study
- Status
- WITHDRAWN
- Phase
- N/A
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Secondary Central Nervous System Lymphoma Registry - Charité
- Status
- RECRUITING
- Phase
- N/A
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
- Status
- RECRUITING
- Phase
- PHASE1
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
- Status
- COMPLETED
- Phase
- N/A
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Two Step Haplo With Radiation Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
IIT2020-20-SHIRAZIP-WALK: Nature Walks
- Status
- COMPLETED
- Phase
- NA
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
huCART19-IL18 in CD19+ Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
SARS-CoV-2 Donor-Recipient Immunity Transfer
- Status
- COMPLETED
- Phase
- N/A
'Re-Priming' RT After Incomplete Response to CAR-T in R/R NHL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2